ProQR Therapeutics (PRQR) Cash & Equivalents (2013 - 2026)
ProQR Therapeutics' Cash & Equivalents was $136.14 million in the quarter ended Jun 30, 2026, up 0.4% from $135.57 million a year earlier and up 43.4% from the prior quarter.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Cash & Equivalents (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Cash & Equivalents at ProQR Therapeutics came in at $104.41 million, down 35.4% from the prior year.
- Cash & Equivalents shows a five-year compound annual growth rate of 3.8% (years ended Dec 2020 to Dec 2025).
- In earlier years, Cash & Equivalents was $161.71 million in the year ended Dec 31, 2024 (+24.6%), $129.81 million in the year ended Dec 31, 2023 (+30.0%), $99.89 million in the year ended Dec 31, 2022 (-99.9%) and $89.75 billion in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Cash & Equivalents since the quarter ended Mar 31, 2025.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 9.0%.
- The best year-over-year quarter for Cash & Equivalents over five years was the quarter ended Dec 31, 2021 (growth of 137.2%); the worst was the quarter ended Dec 31, 2022 (a decline of 54.9%).
- Per Business Quant data, PRQR's Cash & Equivalents in the three quarters before the quarter ended Jun 30, 2026 was $94.93 million (quarter ended Mar 31, 2026), $107.57 million (quarter ended Dec 31, 2025) and $124.95 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | ProQR Therapeutics | 138.02 Mn | -322.63 Mn | - | 133.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133.78 Mn |
| Mar 31, 2026 | 92.93 Mn |
| Dec 31, 2025 | 108.56 Mn |
| Sep 30, 2025 | 125.39 Mn |
| Jun 30, 2025 | 140.45 Mn |
| Mar 31, 2025 | 143.32 Mn |
| Dec 31, 2024 | 155.48 Mn |
| Sep 30, 2024 | 99.86 Mn |
| Jun 30, 2024 | 84.56 Mn |
| Mar 31, 2024 | 92.52 Mn |
| Dec 31, 2023 | 131.63 Mn |
| Sep 30, 2023 | 127.33 Mn |
| Jun 30, 2023 | 139.72 Mn |
| Mar 31, 2023 | 151.56 Mn |
| Dec 31, 2022 | 101.04 Mn |
| Sep 30, 2022 | 98.72 Mn |
| Jun 30, 2022 | 163.39 Mn |
| Mar 31, 2022 | 187.09 Mn |
| Dec 31, 2021 | 212.37 Mn |
| Sep 30, 2021 | 181.15 Mn |
API Access
ProQR Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();